Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.

Merck MECTIZAN® Donation Program

Advancing the Dialogue Toward a Healthier Future

Overview Approach Performance Priorities and Goals

One of the most significant initiatives undertaken by Merck to help improve access to medicines in developing countries is the Merck MECTIZAN® Donation Program. Established more than 20 years ago, the MECTIZAN Donation Program is longest-running disease-specific drug donation program and public/private partnership of its kind in history, and is widely regarded as one of the most successful public/private health collaborations in the world.











The content on this page was last modified on September 15, 2009.

Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.

*Software to view files presented in PDF or SWF format is available at no charge through the Adobe Web site. Get Adobe Reader Get Adobe Flash Player

Copyright © 2009 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.  Privacy  Terms of Use  Sitemap